Main Conference

APPLY TO SPEAK

BOOK YOUR TICKET

 

The World Patient Safety Congress Americas is the largest, most established meeting dedicated to drug safety in the Americas – providing the most up to date, keynote-driven content surrounding the pharmacovigilance space.


From real world evidence & data analytics to safety in advanced therapies, this one meeting covers the whole drug safety value chain where industry leaders, government and developers all come together to create groundbreaking progress.

2026 Keynotes

 

Wednesday, October 14th

Panel - From Defence to Offense: Architecting the Future-Ready Vigilance Strategy Across Pharma, Devices, and Cosmetics

Connected Intelligence: How Agentic AI Is Transforming Life Sciences Operations

The Autonomous Safety Future: Human Judgment + AI Scale

From Promise to Proof: How Sanofi Operationalized Governed AI in Pharmacovigilance at Global Scale

Accelerating Pharmacovigilance Signal Evaluation with AI-Assisted Analytics and Real-World Data

Thursday, October 15th

Panel - Shaping the Future of Patient Safety: Regulatory Perspectives and Roadmaps

Presentation - Making Precision Pharmacovigilance Real: The Future Is Already Here

Panel - From Potential to Trusted Adoption: Scaling Agentic AI in Pharmacovigilance

 

Our world class conference features the following themes

 

AI & Automation
AI & Automation
Discover how artificial intelligence and automation are transforming pharmacovigilance processes, enhancing efficiency, accuracy, and drug safety monitoring.
Global PV
Global PV
Explore global trends in pharmacovigilance and how international regulatory requirements shape drug safety practices.
Regulatory
Regulatory
Stay updated on the latest regulatory developments in drug safety internationally and how to ensure compliance with evolving guidelines
Safety Risk Management
Safety Risk Management
Learn advanced strategies for identifying, assessing, and mitigating risks throughout the drug development lifecycle
Next Gen Tech & Data
Next Gen Tech & Data
Learn first-hand how next-generation technologies and data analytics are revolutionizing pharmacovigilance and enhancing drug safety monitoring.
Real-World Evidence & Data Analytics
Real-World Evidence & Data Analytics
Understand the role of real-world data in generating insights that improve drug safety and patient outcomes.
Patient Centricity
Patient Centricity
Dive into how placing patients at the center of drug safety efforts improves care, reporting, and risk management
PV Education & Training
PV Education & Training
Gain insights into effective PV training programs that ensure a skilled and knowledgeable workforce in drug safety.
PV Outsourcing
PV Outsourcing
Discuss the benefits and challenges of outsourcing pharmacovigilance operations to external partners.
Innovation & Partnerships
Innovation & Partnerships
Learn how collaborations and partnerships are driving innovation in drug safety and pharmacovigilance.
Compliance
Compliance
Hear best practices on navigating the complexities of ensuring drug safety compliance with stringent local and global regulations.
Quality Assurance
Quality Assurance
Explore the importance of maintaining high-quality standards in pharmacovigilance to protect patient safety.
Safety in Advanced Therapies
Safety in Advanced Therapies
Address the unique safety challenges posed by advanced therapies such as gene and cell therapies.
Vaccine Safety
Vaccine Safety
Discuss the latest strategies and challenges in monitoring the safety of vaccines in a rapidly evolving landscape.
MedTech
MedTech
Understand the intersection of pharmacovigilance and medical technology, focusing on the safety monitoring of medical devices.

 

APPLY TO SPEAK

DOWNLOAD PROSPECTUS

Highlighted Speakers
 

Han Ma
Chief Safety Officer
BeiGene USA, Inc.
Han Ma speaking at World Drug Safety Congress
Serban Ghiorghiu
Chief Safety Officer
AstraZeneca
Serban Ghiorghiu speaking at speaking at World Drug Safety Congress
Rania Mouchantaf, PhD
Executive Director
Health Canada
Rania Mouchantaf, PhD speaking at World Drug Safety Congress
Peter Hjelmstrom
Director and CEO
Uppsala Monitoring Centre
Peter Hjelmstrom speaking at World Drug Safety Congress
Jose Vega
Chief Safety Officer
Moderna Therapeutics
Jose Vega speaking at World Drug Safety Congress
Yvonne Nanciu
Country Head, PV, Deputy EU QPPV
Bayer
Yvonne Nanciu speaking at World Drug Safety Congress
Badrish Patel
VP, Global Drug Safety & PV
Jazz Pharmaceuticals
Badrish Patel speaking at World Drug Safety Congress
Claudia Manzo
Head of the Office of Risk Management PV & Patient Safety
AbbVie
Claudia Manzo speaking at World Drug Safety Congress
Mamiko Kasho
Executive Director, Head of Pharmacovigilance Operations
Eisai
Mamiko Kasho speaking at World Drug Safety Congress
Felix Arellano
Global Head of PV & Drug Safety
Roche
Felix Arellano speaking at speaking at World Drug Safety Congress
Reema Mehta
VP, Head of Risk Assessment & Management
Pfizer
Reema Mehta speaking at World Drug Safety Congress
Narayan Nair
Division Director for Division of PV, Center for Biologics Evaluation & Research
FDA
Narayan Nair speaking at World Drug Safety Congress

 

SEE MORE SPEAKERS

Get Involved At patient Safety Congress Americas

 

CONNECT WITH US

 

 

To Sponsor

Kieron Carter
kieron.carter@terrapinn.com

+44 20 3481 8981

 

To Speak

Katherine O'Leary
katherine.oleary@terrapinn.com

 

Marketing & Press

Karolina Bzikot
karolina.bzikot@terrapinn.com